Literature DB >> 23180308

Placental hCG immunohistochemistry and serum free-Beta-hCG at 11-13 weeks' gestation in intrauterine fetal demise.

Ambrogio P Londero1, Maria Orsaria, Tiziana Grassi, Angelo Calcagno, Stefania Marzinotto, Maria Ceraudo, Arrigo Fruscalzo, Lorenza Driul, Laura Mariuzzi.   

Abstract

Intrauterine fetal demise (IUFD) is a continuing problem that can result in severe psychosocial trauma for expecting parents. Our aim was to analyze placental human chorionic gonadotropin (hCG) expression at the third trimester and free-Beta-hCG levels measured at 11-13 weeks in cases of IUFD that occurred after 34 weeks' gestation, alongside a parallel analysis of a set of controls. In this retrospective study we present immunohistochemical data of a tissue microarray that included the following: 12 placentas where IUFD occurred (24 samples); 28 control placentas from first and early second trimester (56 samples); and 30 control placentas at term of pregnancy (60 samples). We used immunohistochemistry to analyze the expression of hCG. Data are also presented from 3,240 first trimester trisomies screening tests, of which 21 pregnancies resulted in IUFD (15 after 22 weeks' gestation and 6 after 34 weeks). All pregnancies took place between 2001 and 2010. For each case, our analysis took account of pregnancy-related data that we gathered from the relevant clinical files. Small for gestational age (SGA) was defined as neonatal weight <10th centile. Our results show that full-term placentas displayed a decreased immunohistochemical expression of hCG in comparison with those at the first trimester (p < 0.05). Moreover, low hCG expression in placentas at the third trimester was shown to be an independent risk factor for IUFD after 34 weeks' gestation (under multivariate analysis with p < 0.05). When we reviewed first trimester screening results, free-Beta-HCG was found to be lower for the group of IUFD after 34 weeks' gestation than in the group of live births (p < 0.05). This difference was heavily weighted by non small for gestational age (non-SGA) associated cases of IUFD: these presented a free-Beta-hCG MoM log of -0.27 (± 0.09) in contrast to just -0.01 (± 0.03) in SGA-associated IUFD (p < 0.05). Our results show that low hCG is an independent risk factor for IUFD after 34 weeks' gestation, and that levels of the hormone are significantly lower in non-SGA associated cases of IUFD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180308     DOI: 10.1007/s00418-012-1054-9

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  29 in total

1.  First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications.

Authors:  C Y Ong; A W Liao; K Spencer; S Munim; K H Nicolaides
Journal:  BJOG       Date:  2000-10       Impact factor: 6.531

2.  Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failures.

Authors:  Yasushi Sasaki; Donald G Ladner; Laurence A Cole
Journal:  Fertil Steril       Date:  2007-08-06       Impact factor: 7.329

3.  Chorionic gonadotropin secretion by human embryos in vitro.

Authors:  D L Hay; A Lopata
Journal:  J Clin Endocrinol Metab       Date:  1988-12       Impact factor: 5.958

4.  Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.

Authors:  K H Nicolaides; K Spencer; K Avgidou; S Faiola; O Falcon
Journal:  Ultrasound Obstet Gynecol       Date:  2005-03       Impact factor: 7.299

Review 5.  First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.

Authors:  K Spencer; N J Cowans; K Avgidou; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2006-10       Impact factor: 7.299

6.  Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope.

Authors:  G Kovalevskaya; S Birken; T Kakuma; N Ozaki; M Sauer; S Lindheim; M Cohen; A Kelly; J Schlatterer; J F O'Connor
Journal:  J Endocrinol       Date:  2002-03       Impact factor: 4.286

7.  Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth.

Authors:  Gordon C S Smith; Emily J Stenhouse; Jennifer A Crossley; David A Aitken; Alan D Cameron; J Michael Connor
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

8.  Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss.

Authors:  Laura Goetzl; David Krantz; Joe Leigh Simpson; Richard K Silver; Julia M Zachary; Eugene Pergament; Lawrence D Platt; Maurice J Mahoney; Ronald J Wapner
Journal:  Obstet Gynecol       Date:  2004-07       Impact factor: 7.661

Review 9.  Biological functions of hCG and hCG-related molecules.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2010-08-24       Impact factor: 5.211

10.  Fetal gender ratio in recurrent miscarriages.

Authors:  Anna Del Fabro; Lorenza Driul; Omar Anis; Ambrogio P Londero; Serena Bertozzi; Livio Bortotto; Diego Marchesoni
Journal:  Int J Womens Health       Date:  2011-07-20
View more
  3 in total

Review 1.  The Histochemistry and Cell Biology compendium: a review of 2012.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2013-05-12       Impact factor: 4.304

Review 2.  The Histochem Cell Biol conspectus: the year 2013 in review.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2014-03-09       Impact factor: 4.304

3.  Is Glycated Hemoglobin A1c Level Associated with Adverse Pregnancy Outcomes of Women Affected by Pre-Gestational Diabetes?

Authors:  Serena Xodo; Ambrogio Pietro Londero; Martina D'Agostin; Alice Novak; Silvia Galasso; Carla Pittini; Giovanni Baccarini; Franco Grimaldi; Lorenza Driul
Journal:  Medicina (Kaunas)       Date:  2021-05-09       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.